EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis

Chiara Rocha, Erin H Doyle, Chip A Bowman iD, M-Isabel Fiel, Ashley E Stueck, Nicolas Goossens, Kian Bichoupan, Neal Patel, James F Crismale, Jasnit Makkar, Sara Lewis, Ponni V Perumalswami und 4 weitere

Cancer Medicine · 2023

DOI: 10.1002/cam4.5711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Chiara Rocha und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery-Transplant Division, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis C, Chronic, Liver Neoplasms, Hepatitis C. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIDA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Successful treatment of hepatitis C reduces liver inflammation and fibrosis; however, patients remain at risk of developing hepatocellular carcinoma (HCC).

Aims

To identify risk factors for new‐onset HCC in patients cured of hepatitis C.

Methods

Imaging, histological, and clinical data on patients whose first HCC was diagnosed >12 months of post‐SVR were analyzed. Histology of 20 nontumor tissues was analyzed in a blinded manner using the Knodel/Ishak/HAI system for necroinflammation and fibrosis/cirrhosis stage and the Brunt system for steatosis/steatohepatitis. Factors associated with post‐SVR HCC were identified by comparison with HALT‐C participants who did not develop post‐SVR HCC.

Results

Hepatocellular carcinoma was diagnosed in 54 patients (45 M/9F), a median of 6 years of post‐SVR [interquartile range (IQR) =1.4‐10y] at a median age of 61 years (IQR, 59–67). Approximately one‐third lacked cirrhosis, and only 11% had steatosis on imaging. The majority (60%) had no steatosis/steatohepatitis in histopathology. The median HAI score was 3 (1.25–4), indicating mild necroinflammation. In a multivariable logistic regression model, post‐SVR HCC was positively associated with non‐Caucasian race ( p = 0.03), smoking ( p = 0.03), age > 60 years at HCC diagnosis ( p = 0.03), albumin1 ( p = 0.05), and platelets

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis C, ChronicLiver NeoplasmsHepatitis CFatty LiverHumansMiddle AgedAgedAntiviral AgentsSustained Virologic ResponseRisk FactorsLiver CirrhosisHepacivirus

Stichwörter der Autor:innen

alpha-fetoproteinhepatitis C virushepatocellular carcinomasustained virological response

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Surgery-Transplant Division, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai School, New York, New York, USA.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Chip A Bowman

Förderung

  • NIDDK NIH HHS
  • NIDA NIH HHS
  • NCI NIH HHS
  • Cancer Prevention and Research Institute of Texas
  • European Commission
  • Irma T. Hirschl Trust
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Drug Abuse

Zitieren

APA

Rocha, C., Doyle, E. H., Bowman, C. A., Fiel, M. I., Stueck, A. E., Goossens, N., Bichoupan, K., Patel, N., Crismale, J. F., Makkar, J., Lewis, S., Perumalswami, P. V., Schiano, T. D., Hoshida, Y., Schwartz, M., & Branch, A. D. (2023). Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis. Cancer Medicine. https://doi.org/10.1002/cam4.5711

Vancouver

Rocha C, Doyle EH, Bowman CA, Fiel MI, Stueck AE, Goossens N, et al. Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis. Cancer Medicine. 2023. doi:10.1002/cam4.5711

BibTeX
@article{Rocha2023,
  author = {Rocha, Chiara and Doyle, Erin H and Bowman, Chip A and Fiel, M-Isabel and Stueck, Ashley E and Goossens, Nicolas and Bichoupan, Kian and Patel, Neal and Crismale, James F and Makkar, Jasnit and Lewis, Sara and Perumalswami, Ponni V and Schiano, Thomas D and Hoshida, Yujin and Schwartz, Myron and Branch, Andrea D},
  title = {Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5711}
}
Kostenlos starten →